miR-3133 inhibits gastrointestinal cancer progression through activation of Hippo and p53 signalling pathways via multi-targets.

Ling ZhouHui GuoQuan LiaoJianping ZouYi LeZiling FangJianping XiongShanshan HuangJun DengXiaojun Xiang

Published in: Journal of cellular and molecular medicine (2023)

miR-3133 inhibits GIC progression by activating the Hippo and p53 signalling pathways via multi-targets, including RNF146, thereby providing prognostic factors and valuable potential therapeutic targets for GIC.

Keyphrases

prognostic factors
cell proliferation
long non coding rna
long noncoding rna
papillary thyroid
signaling pathway
squamous cell
squamous cell carcinoma
oxidative stress
young adults
human health
childhood cancer